Clever Leaves Holdings Inc. (CLVR) vs Citius Oncology, Inc. (CTOR)

Clever Leaves Holdings Inc. and Citius Oncology, Inc. are both Drug Manufacturers Specialty & Generic companies. Clever Leaves Holdings Inc. and Citius Oncology, Inc. are of similar size ($97.6M and $96.5M). Citius Oncology, Inc. has the higher net margin (0.00% vs −102.8%) and the lower return on invested capital (−67.2% vs −52.6%). Across the 12 metrics below, Clever Leaves Holdings Inc. leads on 8 and Citius Oncology, Inc. on 4.

Valuation

Metric CLVR CTOR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B n/m 2.81 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 0.45 n/m 12.29
EV/Sales (0.33) n/m 2.56
Earnings yield 0.00% (44.76%) (2.99%)
Free cash flow yield 0.00% (28.37%) 0.00%

Profitability

Metric CLVR CTOR Drug Manufacturers Specialty & Generic median
Gross margin 37.64% — 53.94%
Operating margin (89.53%) 0.00% 0.00%
Net margin (102.77%) 0.00% 0.00%
Free cash flow margin (49.82%) 0.00% 0.00%
Return on equity (55.39%) (126.58%) (0.40%)
Return on assets (42.95%) (45.20%) (3.32%)
Return on invested capital (52.59%) (67.15%) 0.00%

Growth

Metric CLVR CTOR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 6.14% — 10.01%
EPS growth (last fiscal year) 77.89% (9.68%) —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVR CTOR Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.50 0.05
Current ratio 2.40 0.73 2.31
Net debt to EBITDA 0.45 (0.40) 0.85

Dividend

Metric CLVR CTOR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric CLVR CTOR Drug Manufacturers Specialty & Generic median
Market cap 96.49m 97.63m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack